(Unaudited data)
Cumulative activity as of the end of december 2014
thousands of euros
2013
2014
Variation at current exchange rates
Variation at constant exchange rates
France
346,965
343,891
- 0.9%
- 0.9%
International :
270,766
265,857
- 1.8%
+ 2.7%
Incl. Europe excluding France
204,283
198,918
- 2.6%
+ 2.8%
Incl. North America
53,364
52,813
- 1.0%
+ 0.3%
Incl. Other countries
13,119
14,126
+ 7.7%
+ 9.6%
Group Total
617,731
609,748
- 1.3%
+ 0.7%
thousands of euros
2013
2014
Variation at current exchange rates
Variation at constant exchange rates
Non-proprietary Homeopathic Medicines
305,739
305,501
- 0.1%
+ 0.0%
OTC Specialties
311,581
303,549
- 2.6%
+ 1.2%
Other
411
698
+ 69.8%
+ 67.6%
Group Total
617,731
609,748
- 1.3%
+ 0.7%
Quarterly activity in 2014 ( variation at current rate)
1st Quarter
2nd Quarter
3rd Quarter
4th Quarter
thousands of euros
2013
2014
Var. 14/13
2013
2014
Var. 14/13
2013
2014
Var. 14/13
2013
2014
Var. 14/13
France
84,270
82,749
- 1.8%
75,327
74,269
- 1.4%
92,596
92,466
- 0.1%
94,772
94,407
- 0.4%
International :
73,751
57,460
-22.1%
42,436
47,138
+11.1%
76,890
79,646
+3.6%
77,689
81,613
+5.1%
Incl.Europe excluding France
54,334
39,967
- 26.4%
29,047
33,570
+ 15.6%
61,256
62,758
+ 2.5%
59,646
62,623
+5.0%
Incl. North America
15,562
12,662
- 18.6%
10,017
10,625
+ 6.1%
12,153
13,109
+ 7.9%
15,632
16,417
+5.0%
Incl. Other countries
3,855
4,831
+25.3%
3,372
2,943
- 12.7%
3,481
3,779
+ 8.6%
2,411
2,573
+6.7%
Group Total
158,021
140,209
-11.3%
117,763
121,407
+ 3.1%
169,486
172,112
+1.5%
172,461
176,020
+2.1%
1st Quarter
2nd Quarter
3rd Quarter
4th Quarter
thousands of euros
2013
2014
Var. 14/13
2013
2014
Var. 14/13
2013
2014
Var. 14/13
2013
2014
Var. 14/13
Non-proprietary Homeopathic Medicines
79,062
77,919
- 1.4%
73,035
73,072
+ 0.1%
73,597
72,957
- 0.9%
80,045
81,553
+ 1.9%
OTC Specialties
78,866
62,196
-21.1%
44,600
48,058
+ 7.8%
95,813
99,025
+ 3.4%
92,302
94,270
+ 2.1%
Other
93
94
+1.1%
128
277
+116.4%
76
130
+71.1%
114
197
+72.8%
Group Total
158,021
140,209
-11.3%
117,763
121,407
+ 3.1%
169,486
172,112
+ 1.5%
172,461
176,020
+ 2.1%
Highlights of the fourth quarter
Sales revenue in the fourth quarter of 2014 grew by 2.1% (5.1% at constant rate).
Given the evolution of business and the control of costs, the 2014 operating income should grow in comparison to 2013.
On December 31, 2013, the group's net cash position is close to 156 million euros.
On January 19, 2015, the Superior Court of Montreal rejected the complaint aiming at launching a class action proceeding filed on April 13, 2012.
Our next update: March 18, 2015, after the close of the stock market, publication of 2014 results.
Financial information manager: Christian Boiron
Contact for financial information: Véronique Bouscayrol
Investor relations: +33 (0) 4.78.45.63.43 - e-mail: finances@boiron.fr
ISIN Code: FR0000061129 (BOI) - Bloomberg: BOI FP - Reuters: BOIR.PA
The group's financial information is online at : www.boironfinance.com
Communiqués au titre de l'obligation d'information permanente :
- Communiqué sur comptes, résultats, chiffres d'affaires
Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-38559-BOI-220115-CA-14-GB.pdf
© Copyright Actusnews Wire
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free
Quelle: Actusnews